Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9463 |
High Similarity |
NPD2801 |
Approved |
0.9396 |
High Similarity |
NPD1934 |
Approved |
0.9116 |
High Similarity |
NPD1511 |
Approved |
0.9079 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8993 |
High Similarity |
NPD1512 |
Approved |
0.8961 |
High Similarity |
NPD3882 |
Suspended |
0.8805 |
High Similarity |
NPD6166 |
Phase 2 |
0.8805 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8805 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8718 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.871 |
High Similarity |
NPD1465 |
Phase 2 |
0.8696 |
High Similarity |
NPD3818 |
Discontinued |
0.8671 |
High Similarity |
NPD5494 |
Approved |
0.8649 |
High Similarity |
NPD1549 |
Phase 2 |
0.8589 |
High Similarity |
NPD7074 |
Phase 3 |
0.8581 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8581 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8545 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8535 |
High Similarity |
NPD3817 |
Phase 2 |
0.8528 |
High Similarity |
NPD7054 |
Approved |
0.8476 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8446 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8431 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8425 |
Intermediate Similarity |
NPD943 |
Approved |
0.8425 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8397 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8313 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8313 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8313 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8311 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8272 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8263 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8239 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8221 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8214 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8207 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8204 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8193 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8182 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8151 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8146 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8129 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8125 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8121 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8077 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8075 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8063 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8054 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8054 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8049 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8039 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD447 |
Suspended |
0.8 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7987 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7963 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7952 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7937 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7927 |
Intermediate Similarity |
NPD919 |
Approved |
0.7908 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.787 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7843 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7836 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7821 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7792 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.775 |
Intermediate Similarity |
NPD920 |
Approved |
0.775 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7702 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7692 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7643 |
Intermediate Similarity |
NPD1243 |
Approved |
0.764 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7628 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7627 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7625 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7625 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7625 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7616 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7602 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.759 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7564 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7564 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7546 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7541 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD3748 |
Approved |
0.75 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7484 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7467 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7458 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7457 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7453 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.745 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7438 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7432 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7412 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7326 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD37 |
Approved |
0.7299 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7278 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7278 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7267 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7239 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7232 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.723 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7225 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7219 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7208 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7202 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7191 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7184 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7168 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7168 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7162 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7157 |
Intermediate Similarity |
NPD2899 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7151 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7151 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7127 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7115 |
Intermediate Similarity |
NPD411 |
Approved |
0.7115 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7091 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7078 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7063 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7053 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7047 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7041 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7041 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7033 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7032 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.703 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7005 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.6994 |
Remote Similarity |
NPD2654 |
Approved |
0.6993 |
Remote Similarity |
NPD4749 |
Approved |
0.6989 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6989 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6988 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6975 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6974 |
Remote Similarity |
NPD1201 |
Approved |
0.6963 |
Remote Similarity |
NPD7697 |
Approved |
0.6963 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6963 |
Remote Similarity |
NPD7698 |
Approved |
0.6962 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD4287 |
Approved |
0.6957 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6954 |
Remote Similarity |
NPD17 |
Approved |
0.6943 |
Remote Similarity |
NPD7584 |
Approved |
0.6943 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6941 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD9545 |
Approved |
0.6928 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.6927 |
Remote Similarity |
NPD1729 |
Discontinued |
0.6927 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6927 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD4288 |
Approved |
0.6919 |
Remote Similarity |
NPD2296 |
Approved |
0.6918 |
Remote Similarity |
NPD228 |
Approved |
0.6913 |
Remote Similarity |
NPD9493 |
Approved |
0.6911 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6909 |
Remote Similarity |
NPD2354 |
Approved |
0.6907 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6903 |
Remote Similarity |
NPD2797 |
Approved |
0.6899 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6899 |
Remote Similarity |
NPD3764 |
Approved |
0.6898 |
Remote Similarity |
NPD6535 |
Approved |
0.6898
|
Remote Similarity |
NPD6534 |
Approved |